Showing results (11-20 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|August 25, 2020
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumoniaDennis McGonagle, James S O'Donnell, Kassem Sharif, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
The Lancet. Rheumatology|April 16, 2021
Correction to Lancet Rheumatol 2021; 3: e111-21
The Lancet. Rheumatology|June 13, 2025
Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trialAnnikka Polster, Unni Olsen, Lars Asphaug, et al.
The Lancet. Rheumatology|June 13, 2025
Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging studyKate Harnden, Navkiran Sidhu, Emma Rowbotham, et al.
The Lancet. Rheumatology|May 31, 2025
Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysisHazel J Jenkins, Leticia Corrêa, Benjamin T Brown, et al.
The Lancet. Rheumatology|May 26, 2025
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestationsLaurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, et al.
The Lancet. Rheumatology|November 6, 2025
IgG4-related disease in the Japanese population: a whole-genome sequencing studyYuxun Oswald Zhang, Takeshi Iwasaki, Takahisa Kawaguchi, et al.
The Lancet. Rheumatology|October 2, 2025
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort studyJulien Duquesne, Louis Basseto, Charlotte Claye, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Pageof 47